PHIL and Sprout Pharmaceuticals Expand Affordable Direct-to-Patient Program
Share this article on:
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
